Innovations, Implementations, and Strategies to Advance Patient-Centricity and Business Outcomes Cutting-edge technologies have long played a key role in developing and delivering safe, reliable drugs to market, and yet the adoption of advanced analytics tools such as AI & ML, has been relatively slow in pharma compared to other sectors. For AI to make a true and scalable impact enabling patient centricity and desired business outcomes across drug discovery through commercial applications, outdated innovation models and data strategies must be redefined. This dedicated event brings together pharmaceutical executives to help further drive innovation across data and technology and navigate the implementation of ML & AI and to delve into the subsequent business outcomes. Combining strategic discussions on redefining your AI strategy, the value of AI, ethics and trust, risk mitigation, data quality and implementation success stories, this forum facilitates discussions and partnerships to continue the current AI momentum.